No Detail Found!

Repeated Dexmedetomidine Infusion is a Two-shot Weapon for Pain and Pain-induced Mood Disorders in Chronic Pain Patients: A Placebo-controlled Randomized Prospective Interventional Study

Author(s)
Aml Zakaria Department of Psychiatry, Faculty of Medicine, Suez Canal University
Salsabil SA Ibrahim Department of Anesthesia, Pain & ICU, Faculty of Medicine, Benha University
Islam Shaboob Department of Anesthesia, Pain & ICU, Faculty of Medicine, Benha University
Abstract
This prospective study examined the effects of 6sessions of dexmedetomidine (DEX) for patients had chronic musculoskeletal pain (CMSP) on the frequency and severity of pain, and pain-induced depression, anxiety and kinesiophobia. Patients & Methods: 80 CMSP patients were evaluated using the short-form McGill Pain Questionnaire (SF-MPQ), Pain Anxiety Symptoms Scale (PASS), State-Trait Anxiety Inventory for measuring state and trait anxiety, short-form Tampa Scale of Kinesiophobia and Beck Depression Inventory-II. Patients were randomly divided into Group-C received placebo infusion and Group-S received DEX infusion (0.7 µg/kg for 1-hour) twice weekly for three weeks. Evaluations were re-assessed at the end of infusion (T2), 1-m (T3) and 3-m (T4) in comparison to scores determined before start of infusion therapy (T1). Results: At T2-T4 the scores of all the evaluated tools decreased significantly in Group-S compared their T1 scores and to scores of patients of Group-C. Moreover, 47.5% of Group-S patients were independent on any analgesia since T2 till T4 with significant difference compared to Group-C patients and to their consumption rate and type of analgesia at T1. Satisfaction scores of Group-S patients by the infusion therapy were significantly higher compared to that of patients of Group-C and to their T1 scores by the usual analgesia. The re-assessed scores were negatively correlated with the administration of DEX infusion and positively correlated with the decrease in pain scores. ROC curve analysis defined decreased kinesiophobia scores as the significant predictor for the decreased depression scores to 0-13. Conclusion: DEX infusion might break the circle of painpsychopathy-poor quality of life of CMSP patients. All psychological scorings were improved secondary to improved pain scores but improved kinesiophobia is the significant predictor for alleviation of depression.
Publication Details
Page(s) 761-770
DOI DOI not available
Published Journal: International Journal of Communication Networks and Information Security, Volume: 16, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
anxiety, Dexmedetomidine, Depression, Kinesiophobia, Chronic musculoskeletal pain
References
.2024 .Chronic stress induces wide-spread hyperalgesia: The involvement of spinal CCK1 receptors. Neuropharmacology. 2024 Nov, 110067 : 110067.
Tang K,Sun J,Dong Y,Zheng Z,Wang R,Lin N,Chen W . .Topical Chinese patent medicines for chronic musculoskeletal pain: systematic review and trial sequential analysis BMC MusculoskeletDisord. 2023 Dec, 10(1) : 985.
Yang P,Wang T,He Y,Su S . .Research Trends of Acupuncture Therapy for Chronic PainRelated Depression or Anxiety from 2003 to 2023: A Bibliometric Analysis. J Pain Res. 2023 Dec, 10 : 4301-4315.
Reitan Åström,Wicksell JLM,RK JLM .2024 .Associations between sickness behavior, but not inflammatory cytokines, and psychiatric comorbidity in chronic pain. Psychoneuroendocrinology, 107094 : 107094.
Al-Alawi M,Brietzke E,Carvalhal A,Soares C . .The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence. Rev Neurosci. 2020 Aug, 10(6) : 649-658.
.2024 .Dexmedetomidine enhances Mitophagy via PINK1 to alleviate hippocampal neuronal Pyroptosis and improve postoperative cognitive dysfunction in elderly rat. Exp Neurol, 114842 : 114842.
.2024 .Alleviation effects of dexmedetomidine on myocardial ischemia/reperfusion injury through fatty acid metabolism pathway via Elovl6. 2024 Sep, 112588 : 112588.
Melzack R . .The short-form McGill Pain Questionnaire. Pain, 10(87) : 91074-8.
McCracken LM,Dhingra L .2002 .A short version of the Pain Anxiety Symptoms Scale (PASS-20): preliminary development and validity. Pain Res Manag, 10(1) : 45-50.
Spielberger CD,Lushene RE,Jacobs GA,STAI (Form Y) Palo Alto .1983 .Manual for the State-Trait Anxiety Inventory. , : .
a Bilgin S,Seymenoglu G,Deveci A . .State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections. Biomed Hub, 2(2) : 1-5.
Kori SH .1990 .Kinesiophobia: a new view of chronic pain behavior. Pain Manage, 3 : 35-43.
Woby SR,Roach NK,Urmston M,Watson PJ .2005 .Psychometric properties of the TSK-11: a shortened version of the Tampa Scale for Kinesiophobia. Pain, 117 : 137-144.
Beck AT,Steer RA,Brown GK .1996 .BDI-II, Beck Depression Inventory: Manual. , : .
Aitken RC . .Measurement of feelings using visual analogue scales. Proc R Soc Med, 62(10) : 989-93.
Faul F,Erdfelder E,Lang AG,Buchner A .2007 .G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39 : 175-191.
.2019 .Neurocognitive performance under combined regimens of ketamine-dexmedetomidine and ketaminefentanyl in healthy adults: A randomised trial. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug, 109647 : 109647.
.2024 .Autogenic training for chronic health conditions: A service evaluation. J Eval Clin Pract, 10(6) : 1024-1028.
Anderson B .2024 .Rumination as Predictors of Substance Use, Mental Health, and Pain Outcomes Among People Living With HIV. Behav Ther, 02(5) : 1015-1025.
. .AbdelgalilA: Ultrasound-guided continuous erector spinae plane block vs continuous thoracic epidural analgesia for the management of acute and chronic postthoracotomy pain: a randomized, controlled, double-blind trial. 2023 Nov, 10(6) : e1106.
Sheikh H,Baig T . .Dexmedetomidine as an Adjunct in a Fluoroscopically Guided Stellate Ganglion Block for Complex Regional Pain Syndrome. Cureus. 2023 Jun, 10(6) : e40504.
. .Dexmedetomidine Prevents Chronic Incisional Pain After Brain Tumor Resection: A Secondary Analysis of the Randomized Control Trial. AnesthAnalg. 2024 Apr, 10(4) : 839-847.
Pan T .2022 .Dexmedetomidine alleviates anxiety-like behavior in mice following peripheral nerve injury by reducing thehyperactivity of glutamatergic neurons in the anterior cingulate cortex. BiochemPharmacol, 115293 : 115293.
Jiang N .2023 .Dexmedetomidine alleviates anxiety-like behaviors in female mice with musculoskeletal pain through SIRT1/p53 axis. Brain Res Bull, 110698 : 110698.
Stress Oxidative . .Dexmedetomidine Improves Anxiety-like Behaviors in Sleep-Deprived Mice by Inhibiting the p38/MSK1/NFκB Pathway and Reducing Inflammation. Brain Sci. 2023 Jul, 10(7) : 1058.
. .Dexmedetomidine Inhibits Paraventricular Corticotropin-releasing Hormone Neurons that Attenuate Acute Stress-induced Anxiety-like Behavior in Mice. Anesthesiology. 2024 Jun, 10(6) : 1134-1152.
. .Effects of dexmedetomidine combined with etomidate on postoperative cognitive function in older patients undergoing total intravenous anaesthesia: a randomized, double-blind, controlled trial. 2024 Jan, 10(1) : 97.
.2022 .Dexmedetomidine Alleviates Neuropathic Pain-Induced Depression by Increasing Neurogenesis in the Hippocampus. Pharmacology, 107(5-6) : 31.
.2022 .Dexmedetomidine Regulates the miR-146a-5p/NF- κ B Axis to Alleviate Electroconvulsive Therapy-Induced Cognitive Impairments. 2022 Oct, 10 : 8371492.
.2023 .Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression: A Randomized Clinical Trial. 2024 Jan, 53252(1) : e2353252.
.2024 .Perioperative intravenous infusion of dexmedetomidine for alleviating postpartum depression after cesarean section: A metaanalysis and systematic review. Eur J ObstetGynecolReprod Biol, 03 : 333-341.
Xu S .2023 .Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression. J Affect Disord. 2024 Feb, 11 : 437-444.
0

Citations

0

Downloads

50

Views